User profiles for Antonia Ho
 | Antonia HoClinical senior lecturer, MRC-University of Glasgow Centre for Virus Research Verified email at glasgow.ac.uk Cited by 15910 |
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Objective To characterise the clinical features of patients admitted to hospital with coronavirus
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Background Viral load kinetics and duration of viral shedding are important determinants for
disease transmission. We aimed to characterise viral load dynamics, duration of viral RNA …
disease transmission. We aimed to characterise viral load dynamics, duration of viral RNA …
[HTML][HTML] Genetic mechanisms of critical illness in COVID-19
Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates
…, DAT Cummings, A Ho… - … of the Royal …, 2021 - royalsocietypublishing.org
Since it was first identified, the epidemic scale of the recently emerged novel coronavirus (2019-nCoV)
in Wuhan, China, has increased rapidly, with cases arising across China and …
in Wuhan, China, has increased rapidly, with cases arising across China and …
[HTML][HTML] COVID-19 pandemic—a focused review for clinicians
M Cevik, CGG Bamford, A Ho - Clinical Microbiology and Infection, 2020 - Elsevier
Background The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue
for global health, economics and society. A wealth of data has been generated since its …
for global health, economics and society. A wealth of data has been generated since its …
[HTML][HTML] Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation …
…, P Bannister, CD Russell, L Goodwin, A Ho… - The Lancet Regional …, 2021 - thelancet.com
Background This study sought to establish the long-term effects of Covid-19 following
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
[PDF][PDF] Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…